Exchange: NYSE
Industry: Nonlife Insurance
Last Trade: 4:01 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
44,720,000 | 41,050,000 | 38,546,000 | 38,147,000 | 37,955,000 |
Cost of Goods Sold (COGS) incl. D&A |
33,602,000 | 31,165,000 | 30,059,000 | 29,446,000 | 29,743,000 |
COGS excluding D&A |
31,886,000 | 29,660,000 | 28,546,000 | 28,193,000 | 28,234,000 |
Depreciation & Amortization Expense |
1,716,000 | 1,505,000 | 1,513,000 | 1,253,000 | 1,509,000 |
Gross Income |
11,118,000 | 9,885,000 | 8,487,000 | 8,701,000 | 8,212,000 |
SG&A Expense |
3,026,000 | 2,573,000 | 2,476,000 | 2,428,000 | 2,408,000 |
Research & Development |
0 | 0 | 0 | 0 | 0 |
Other SG&A |
3,026,000 | 2,573,000 | 2,476,000 | 2,428,000 | 2,408,000 |
Other Operating Expense |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
0 | 0 | 0 | NA | 0 |
Non Operating Income/Expense |
-673,000 | -684,000 | -700,000 | -651,000 | -677,000 |
Equity in Affiliates (Pretax) |
NA | 0 | 0 | 0 | 0 |
Interest Expense |
665,000 | 692,000 | 696,000 | 691,000 | 675,000 |
Gross Interest Expense |
665,000 | 692,000 | 696,000 | 691,000 | 675,000 |
Pretax Income |
6,754,000 | 5,936,000 | 4,615,000 | 4,931,000 | 4,452,000 |
Income Tax |
2,093,000 | 1,882,000 | 1,384,000 | 1,565,000 | 1,261,000 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 0 |
Consolidated Net Income |
4,661,000 | 4,054,000 | 3,231,000 | 3,366,000 | 3,191,000 |
Minority Interest Expense |
110,000 | 134,000 | 123,000 | 121,000 | 143,000 |
Net Income |
4,551,000 | 3,920,000 | 3,108,000 | 3,245,000 | 3,048,000 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | NA | 0 | 0 |
Net Income After Extraordinaries |
4,551,000 | 3,920,000 | 3,108,000 | 3,244,999 | 3,048,000 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
4,551,000 | 3,920,000 | 3,108,000 | 3,245,000 | 3,048,000 |
Operational EPS |
1.84 | 1.58 | 1.25 | 1.31 | 1.23 |
EPS (basic) |
1.84 | 1.58 | 1.25 | 1.31 | 1.23 |
EBITDA |
9,808,000 | 8,817,000 | 7,524,000 | 7,526,000 | 7,313,000 |
Depreciation & Amortization Expense |
1,716,000 | 1,505,000 | 1,513,000 | 1,253,000 | 1,509,000 |
Common Shares Outstanding |
2,476,941 | 2,478,276 | 2,477,266 | 2,476,416 | 2,474,836 |
Basic Shares Outstanding |
2,476,941 | 2,478,276 | 2,477,266 | 2,476,416 | 2,474,836 |
Diluted Shares Outstanding |
2,476,941 | 2,478,276 | 2,477,266 | 2,476,416 | 2,474,836 |
Diluted EPS after Extraordinary Items |
1.84 | 1.58 | 1.25 | 1.31 | 1.23 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
1.84 | 1.58 | 1.25 | 1.31 | 1.23 |
*Figures in thousands of U.S. Dollars except shares outstanding.
